Current Status and Countermeasures for the Development of the Chinese Ginseng Industry

doi:10.19894/j.issn.1000-0518.240435

Chinese Journal of Applied Chemistry ›› 2025, Vol. 42 ›› Issue (9): 1282-1288.DOI: 10.19894/j.issn.1000-0518.240435

• Ginseng Column • Previous Articles Next Articles

Current Status and Countermeasures for the Development of the Chinese Ginseng Industry

Chun-Li ZHAO¹, Cheng-Guo LI², Fang XIA¹, Tie-Jun MAO³, Zheng XIE¹, Yu-Fang HE¹()

^1.College of Management，Changchun University of Chinese Medicine，Changchun 130117，China
^2.Changchun Hongyu Technology Co. ，Ltd. ，Changchun 130507，China
^3.State Key Laboratory of Supramolecular Structure and Materials，College of Chemistry，Jilin University，Changchun 130012，China

Received:2024-12-31 Accepted:2025-07-11 Published:2025-09-01 Online:2025-09-28
Contact: Yu-Fang HE
About author:heyufang1992@126.com
Supported by:
the Research Project on the Precision Consultation of Changchun Association for Science and Technology(CCKX-2025-01B)

Abstract

Abstract:

Ginseng has the outstanding effects of preventing and combating cancer， nourishing the body to make it strong， replenishing qi and blood， enhancing the immune system and prolonging the life span， etc. It occupies a unique and irreplaceable key position in the rich treasure trove of traditional Chinese medicine in our country， and enjoys the high reputation of “the king of all medicines”. The prosperous development of ginseng industry has a key demonstration and promotion value for the overall Chinese medicine industry in China， which can provide a strong driving force and a clear development direction for the comprehensive progress of Chinese medicine industry. In this paper， by combing the status quo and existing problems of China's ginseng industry， the experience is summarised and analysed， and suggestions are put forward with a view to promoting the prosperity of China's ginseng industry again.

Key words: China, Ginseng industry, Traditional Chinese medicine, Counterplan

CLC Number:

O629

Chun-Li ZHAO, Cheng-Guo LI, Fang XIA, Tie-Jun MAO, Zheng XIE, Yu-Fang HE. Current Status and Countermeasures for the Development of the Chinese Ginseng Industry[J]. Chinese Journal of Applied Chemistry, 2025, 42(9): 1282-1288.

References 26

[1]	沈彦龙，程立业，孟祥茹，等. 人参连作土壤对不同生育期人参生长发育及抗氧化系统的影响［J］. 应用化学， 2023， 40（1）： 109-115.
	SHEN Y L， CHENG L Y， MENG X R， et al. Effects of ginseng continuous soil crop on growth development and antioxidant system of ginseng at different fertility stages［J］. Chin J Appl Chem， 2023， 40（1）： 109-115.
[2]	ROCTOR J T A， BAILEY W G. Ginseng industry， botany， and culture［J］. Hortic Rev， 1987， 9： 187-236.
[3]	中国药典. 一部［S］. 2010： 8.
	Chinese Pharmacopoeia. Part I ［S］. 2010： 8.
[4]	ZHANG G， LIU A， ZHOU Y， et al. Panax ginseng ginsenoside-Rg2 protects memory impairment via anti-apoptosis in a rat model with vascular dementia［J］. J Ethnopharmacol， 2008， 115（3）： 441.
[5]	YU X T， WANG S P. Clinical observation on treatment for postoperative gastric cancer by ginsenoside Rg3 combined with chemo therapy［J］. Chin J Cancer Prev Treat， 2010， 17（10）： 779.
[6]	MIAO X， LV P， WANG L， et al. Effects of different plant-derived fermentation products as soil amendments on microbial community structure and mitigation of soil degradation caused by replanting［J］. Chem Biol Technol Ag， 2025， 12（1）： 30-30.
[7]	孟璐璐，赵光远. 吉林省人参产业发展的现状及思考［J］. 社会科学战线， 2011（12）： 247-248.
	MENG L L， ZHAO G Y. Current situation and thoughts on the development of ginseng industry in Jilin province［J］. Soc Sci Front， 2011（12）： 247-248.
[8]	彭浩，吕龙石. 中国人参药用和种植史及关键种植技术研究［J］. 安徽农业科学， 2012， 40（20）： 10400.
	PENG H， LV L S. Medicinal and cultivation history of Panax ginseng and its key cultivation technologies［J］. Anhui Agric Sci， 2012， 40（20）： 10400.
[9]	赵英，刘学周，潘文涛，等. 我国人参产业实施专利战略的思考［J］. 中草药， 2010， 41（10）： 1729-1732.
	ZHAO Y， LIU X Z， PAN W T， et al. Reflection on implementation of patent strategy for ginseng industry in China［J］. Chin Herb Med， 2010， 41（10）： 1729-1732.
[10]	戴昀弟. 人参产业可持续发展对策探讨［J］. 社会科学战线， 2007（5）： 68-70.
	DAI Y D. Countermeasures for sustainable development of ginseng industry［J］. Soc Sci Front， 2007（5）： 68-70.
[11]	宋心东，张国荣，赵岩. 我国人参种植业现状与发展趋势［J］. 人参研究， 2013， 25（3）： 43-45.
	SONG X D， ZHANG G R， ZHAO Y. Current situation and development trend of ginseng cultivation in China［J］. Ginseng Res， 2013， 25（3）： 43-45.
[12]	赵亚会，辜旭辉，吴连举，等. 栽培人参种质资源的类别、特点和利用价值研究概况［J］. 中草药， 2007（2）： 294-296.
	ZHAO Y H， GU X H， WU L J， et al. Researches on categories， characteristics， and utilization value of cultivated ginseng germplasm resources［J］. Chin Herb Med， 2007（2）： 294-296.
[13]	IN-HO B， SEUNG-HO S. The world ginseng market and the ginseng （Korea）［J］. J Ginseng Res， 2013， 37（1）： 1-7.
[14]	RATAN Z A， HAIDERE M F， HONG Y H， et al. Pharmacological potential of ginseng and its major component ginsenosides［J］. J Ginseng Res， 2021， 45（2）： 199-210.
[15]	YI Y S. Potential benefits of ginseng against COVID-19 by targeting inflammasomes［J］. J Ginseng Res， 2022， 46（6）： 722-730.
[16]	权申春，梁艳丽，宋贤武，等. 道地中药材昭参资源的研究与利用［J/OL］. 分子植物育种， 1-15［2025-03-10］.
	QUAN S C， LIANG Y L， SONG X W， et al. Research and utilization of genuine Chinese herbal medicine resources of Panax japonicus［J/OL］. Molecular Plant Breeding， 1-15［2025-03-10］.
[17]	杨新富. 发展林业经济解决农村耕地撂荒难题［J］. 新农业， 2021（16）： 53-54.
	YANG X F. Development of forestry economy to solve the problem of rural arable land abandonment［J］. New Agric， 2021（16）： 53-54.
[18]	吉林省统计局. 吉林统计年鉴2018［M］. 北京：中国统计出版社， 2018： 1.
	Jilin Provincial Bureau of Statistics. Jilin Statistical Yearbook 2018［M］. Beijing： China Statistics Press， 2018： 1.
[19]	吉林省统计局. 吉林统计年鉴2019［M］. 北京：中国统计出版社， 2019：1.
	Jilin Provincial Bureau of Statistics. Jilin Statistical Yearbook 2019［M］. Beijing： China Statistics Press， 2019： 1.
[20]	吉林省统计局. 吉林统计年鉴2020［M］. 北京：中国统计出版社， 2020： 1.
	Jilin Provincial Bureau of Statistics. Jilin Statistical Yearbook 2020［M］. Beijing： China Statistics Press， 2020： 1.
[21]	吉林省统计局. 吉林统计年鉴2021［M］. 北京：中国统计出版社， 2021： 1.
	Jilin Provincial Bureau of Statistics. Jilin Statistical Yearbook 2021［M］. Beijing： China Statistics Press， 2021： 1.
[22]	吉林省统计局. 吉林统计年鉴2022［M］. 北京：中国统计出版社， 2022： 1.
	Jilin Provincial Bureau of Statistics. Jilin Statistical Yearbook 2022［M］. Beijing： China Statistics Press， 2022： 1.
[23]	陈兴福，卢进，刘玲. 谈中药材生产基地的建设［J］. 中药材， 1998（2）： 99-102.
	CHEN X F， LU J， LIU L. On the construction of production bases for Chinese medicinal materials［J］. Chin Med Mater， 1998（2）： 99-102.
[24]	张丽萍，杨世林，杨春清，等. 我国药材种子种苗产业存在的问题及其对策［J］. 中国中药杂志， 1999（10）： 3-5.
	ZHANG L P， YANG S L， YANG C Q， et al. Problems and countermeasures in China's medicinal seed and seedling industry［J］. Chin J Tradition Chin Med， 1999（10）： 3-5.
[25]	彭亮亮，董宇，刘强，等. 吉林省长白山地区人参产业发展现状问题及对策［J］. 南方农业， 2024， 18（11）： 175-177.
	PENG L L， DONG Y， LIU Q， et al. The current situation， problems and countermeasures of the ginseng industry development in Changbai mountain area， Jilin province［J］. Southern Agric， 2024， 18（11）： 175-177.
[26]	梁子钰，徐睿瑶. 人参在海外的研究应用概况［J］. 世界中西医结合杂志， 2014， 9（6）： 662-663.
	LIANG Z Y， XU R Y. An overview of the research and application of ginseng overseas［J］. World J Integr Tradit West Med， 2014， 9（6）： 662-663.

Current Status and Countermeasures for the Development of the Chinese Ginseng Industry

RichHTML

PDF

Knowledge

Abstract

Cite this article

share this article

References 26

Related Articles 2

Recommended Articles

Metrics

Comments

[1]	Yi LONG, Guo-Yong LUO, Jian XU, Wen-Fen XU, Jing-Xin DING, Biao CHEN, Jie LIU, Yao LIU, Teng CHEN, Qian LI, Wu-De YANG. Exploration and Practice of Traditional Chinese Medicine in the Teaching of ‘Comprehensive Experiment in Pharmacy’ [J]. Chinese Journal of Applied Chemistry, 2025, 42(1): 107-116.
[2]	JIA Zehui1, WANG Chuntao1, LI Hua2*. The Applications of Multivariate Curve Resolution-alternating Least Squares in Resolving Overlapped Spectra of Corydalis yanhusuo Fingerprint and the Content Detection of Tetrahydropalmatine [J]. Chinese Journal of Applied Chemistry, 2013, 30(03): 329-334.